NATAN DAVID 1253108 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-28 | 2023-07-26 | 2023-07-26 | 4 | Natan David | DIRECTOR | acq | 50000.0 | 100.0 | 33.3 | 0.0 | Direct | Common Stock | TITAN PHARMACEUTICALS INC | code A | 50000.0 | 15.02 (TTNP) |
| 2023-07-31 | 2023-07-26 | 2023-07-26 | 4/A | Natan David | DIRECTOR | acq | 50000.0 | 100.0 | 33.3 | 0.0 | Direct | Common Stock | TITAN PHARMACEUTICALS INC | code A | 50000.0 | 15.02 (TTNP) |
| 2023-10-26 | 2023-10-25 | 2023-10-25 | 4 | Natan David | DIRECTOR | acq | 16250.0 | 24.53 | 10.82 | 0.0 | Direct | Common Stock | TITAN PHARMACEUTICALS INC | code A | 66250.0 | 15.02 (TTNP) |
| 2024-01-24 | 2024-01-22 | 2024-01-22 | 4 | Natan David | DIRECTOR | acq | 25000.0 | 100.0 | 94.96 | 0.0 | Direct | Common Stock | MINIM, INC. | code A | 25000.0 | 2.63 (MINM) |
| 2024-01-24 | 2023-11-08 | 3 | Natan David | DIRECTOR | holding | 0.0 | 0 | 0.0 | 0.0 | Direct | Common Stock | MINIM, INC. | NA | 2.63 (MINM) | ||
| 2024-04-03 | 2024-03-25 | 3 | Natan David | DIRECTOR | holding | 0.0 | 0 | 0.0 | 0.0 | Direct | Common Stock | OPGEN INC | NA | 10.01 (OPGN) | ||
| 2024-04-12 | 2024-04-11 | 2024-04-11 | 4 | Natan David | DIRECTOR | acq | 100000.0 | 100.0 | 99.86 | 0.0 | Direct | Common Stock | OPGEN INC | code A | 100000.0 | 10.01 (OPGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-28 | 2023-07-26 | 2023-06-29 | 4 | Natan David | DIRECTOR | acq | 125000.0 | 100 | 83.24 | 1.35 | Direct | Option To Purchase Common Stock | TITAN PHARMACEUTICALS INC | code A | 100000.0
|
15.02 (TTNP) |
| 2023-07-31 | 2023-07-26 | 2023-06-29 | 4/A | Natan David | DIRECTOR | acq | 125000.0 | 100 | 83.24 | 1.35 | Direct | Option To Purchase Common Stock | TITAN PHARMACEUTICALS INC | code A | 100000.0
|
15.02 (TTNP) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)